|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Development, Vol 122, Issue 6 1759-1767, Copyright © 1996 by Company of Biologists
JOURNAL ARTICLES |
L Schuger, GR Johnson, K Gilbride, GD Plowman and R Mandel
Department of Pathology and Laboratory Medicine, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Epithelial and mesenchymal cells isolated from mouse embryonic lungs synthesized and responded to amphiregulin (AR) in a different fashion. Mesenchymal cells produced and deposited 3- to 4-fold more AR than epithelial cells, proliferated in the presence of exogenous AR, and their spontaneous growth was blocked by up to 85% by anti-AR antibodies. In contrast, epithelial cells exhibited a broad response to this growth regulator factor depending on whether they were supplemented with extracellular matrix (ECM) and whether this ECM was of epithelial or mesenchymal origin. AR-treated epithelial cells proliferated by up to 3-fold in the presence of mesenchymal-deposited ECM, remained unchanged in the presence of epithelial-deposited ECM, and decreased in their proliferation rate below controls in the absence of ECM supplementation. This effect was abolished by treatment with the glycosaminoglycan-degrading enzymes heparinase and heparitinase suggesting the specific involvement of heparan sulfate proteoglycan (HSPG) in AR-mediated cell proliferation. In whole lung explants, branching morphogenesis was inhibited by antibodies against the AR heparan sulfate binding site and stimulated by exogenous AR. Since during development, epithelial cells are in contact with mesenchymal ECM at the tips of the growing buds and alongside the basement membrane, focal variations in the proportion of epithelial and mesenchymal HSPG will focally affect epithelial proliferation rates. Therefore, AR-HSPG interaction may underlie the process of branching morphogenesis by inducing differential cell proliferation.
This article has been cited by other articles:
|
|
 |
|
  N. Heldring, A. Pike, S. Andersson, J. Matthews, G. Cheng, J. Hartman, M. Tujague, A. Strom, E. Treuter, M. Warner, et al. Estrogen Receptors: How Do They Signal and What Are Their Targets Physiol Rev, July 1, 2007; 87(3): 905 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ciarloni, S. Mallepell, and C. Brisken Amphiregulin is an essential mediator of estrogen receptor {alpha} function in mammary gland development PNAS, March 27, 2007; 104(13): 5455 - 5460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. SH. Choi, M. A. Miller, and P. A. Harper In Utero Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Amphiregulin Gene Expression in the Developing Mouse Ureter Toxicol. Sci., November 1, 2006; 94(1): 163 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Sternlicht, S. W. Sunnarborg, H. Kouros-Mehr, Y. Yu, D. C. Lee, and Z. Werb Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin Development, September 1, 2005; 132(17): 3923 - 3933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Abbott, A. R. Buckalew, M. J. DeVito, D. Ross, P. L. Bryant, and J. E. Schmid EGF and TGF-{alpha} Expression Influence the Developmental Toxicity of TCDD: Dose Response and AhR Phenotype in EGF, TGF-{alpha}, and EGF + TGF-{alpha} Knockout Mice Toxicol. Sci., January 1, 2003; 71(1): 84 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Kheradmand, K. Rishi, and Z. Werb Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2 J. Cell Sci., February 15, 2002; 115(4): 839 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Luetteke, T. Qiu, S. Fenton, K. Troyer, R. Riedel, A Chang, and D. Lee Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development Development, January 6, 1999; 126(12): 2739 - 2750. [Abstract] [PDF]
|
|
